Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human p75 NGF Receptor ELISA Kit (AC3441)
Cat.#: ASET-2030
Specifications
Description Human p75 NGF Receptor ELISA Kit allows for the in vitro quantitative determination of human p75 NGF Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2433 Human Calnexin ELISA Kit (AC3844) Quantitative inquiry ASET-1339 Human YWHAE ELISA Kit (AC2750) Quantitative inquiry ASET-2529 Rat Parvalbumin alpha ELISA Kit (AC3940) Quantitative inquiry ASET-1604 Rabbit IL-6 ELISA Kit (AC3015) Quantitative inquiry ASET-1927 Human NK-1R ELISA Kit (AC3338) Quantitative inquiry ASET-2122 Human COMT ELISA Kit (AC3533) Quantitative inquiry ASET-1142 Human SHANK3 ELISA Kit (AC2553) Quantitative inquiry ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-1581 Human PLXNA3 ELISA Kit (AC2992) Quantitative inquiry ASET-1099 Human FTO ELISA Kit (AC2510) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket